Jim Scibetta is the CEO of VectorY Therapeutics, bringing over 20 years of executive leadership experience in biotechnology. They previously served as CEO of Maverick Therapeutics, guiding the company to its acquisition by Takeda, and as President of Pacira BioSciences, where they helped transform it into a public company valued at over $2 billion. Scibetta held various leadership roles, including CFO of BioEnvision and Merrimack Pharmaceuticals, and has been involved with several other biotech companies as a board member and consultant. They earned an MBA in Finance from the University of Michigan and a BS in Physics from Wake Forest University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices